420 with CNW – Why Looking at Indica or Sativa Categorizations Isn’t the Best Way to Select Cannabis Products

Once in a while at your local dispensary, you will hear clients referring to indica or sativa when choosing the marijuana products they want to purchase. These terms are mostly used to describe the characteristics and effects of cannabis buds. Products such as vapes or edibles also lay claim to these terms.

Indica-dominant strains are chill, and sativa strains are energetic. Hybrid strains represent a balance between indica and sativa. The question on people’s minds is, is the classification of the marijuana strains accurate in predicting a person’s experience after using marijuana?

According to Daniel Simone Brand, it is not always accurate classifying weed with people’s experiences. Discussed below is the reason why indica, sativa, and hybrid classification is not reliable and what is replacing them.

Origin of Indica and Sativa

Back in the 1700s, the French biologist Jean Baptiste Lamarck classified weed into cannabis sativa and cannabis indica. According to Lamarck, a cannabis sativa plant was tall with light-colored, pointy shaped leaves while the cannabis indica plant was short with broader, dark-colored leaves.

In those centuries, there were no labs for in-depth testing, but the THC levels were much lower those days than today, and the terpene content could not be determined.

In an interview with HelloMD, Dr. Patricia Frye said that the 18th-century marijuana classification was based on the outward appearance of the crop, not on its genes or effects on the person using. Therefore labeling a plant indica or sativa does not correlate with their impact today.

Cannabinoid Compounds of Cannabis

What matters in a marijuana strain is the level of CBD, THC, and the ratios between them. THC is the psychoactive compound of marijuana responsible for giving a high effect. It can be used medically to treat cancer, chronic pain, and insomnia. CBD is the non-psychoactive compound of cannabis. It can be used to manage various illnesses, such as seizures, anxiety, and inflammation. Recreational consumers can use both THC and CBD products in varying ratios, depending on what they want to achieve.

According to Dr. Frye, consumers should be careful not to overdose on marijuana as it can result in worse symptoms such as paranoia and panic attacks.

Marijuana users are also interested in other cannabinoids such as THCV, CBG, and CBN because of their healing effects. Basing one’s choice on indica or sativa classifications is therefore inadequate.

Terpene Composition

Terpenes influence the taste and the aroma of a strain. The most common types of terpenes found in weed are Caryophyllene, myrcene, limonene, linalool, Pinene, and terpinolene. Each of them has unique characteristics.

According to Dr. Frye, strains containing Myrcene and linalool are best for inducing sleep; limonene, and caryophyllene are suitable for pain relief, while asthmatic patients can use pinene for bronchodilation and anti-inflammatory effects.

According to Alec Dixon, the co-founder, and director of client relations at SC Labs, consumers should be trained to develop their nose to identify potent strains instead of relying on a marijuana strain’s name. He adds that due to the advancements in the cannabis sector, consumers can now rely on researched data instead of hearsay.

Such information may explain why cannabis companies like Cannabis Strategic Ventures Inc. (OTCQB: NUGS) and Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) probably insist that marijuana dispensaries have a budtender to explain the attributes of each product before customers or patients buy it.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – Eagle Labs Announces Launch of impirica CBD Brand

Eagle Labs Inc. on Wednesday announced the launch of impirica (www.impirica.co), a new cannabidiol (“CBD”) brand intended to eliminate consumer hesitancy and increase confidence of those interested in trying CBD products. According to the update, Eagle Labs has taken numerous steps to differentiate impirica from other CBD products in the exciting and highly competitive market. “The impirica brand is strategically designed and looks different than most CBD brands — the brand name itself connotes testing and trust, and you won’t find a hemp leaf anywhere on the packaging,” Eagle Labs Chief Commercial Officer Michael Law said in the news release. “In addition, truth and transparency are of the utmost importance, which is why every product we sell has a QR code on the label that takes you directly to the product testing results.”

To view the full press release, visit http://cnw.fm/7oiJx

About Eagle Labs Inc.

Eagle Labs manufactures the highest quality and most rigorously tested nutritional supplements and skin care products in the USA. The company provides complete, flexible formulating and manufacturing services for private label lines, specializing in working with businesses who are interested in developing high-quality products in smaller quantities. In addition, Eagle Labs has its own line of cannabidiol (“CBD”) products under its impirica brand, which includes tinctures, capsules, soft gels, topical skin creams, a roll-on, and a transdermal patch all tested by multiple independent labs to ensure consumer safety. For more information, visit the company’s website at www.EagleLabsInc.com.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Surna Inc. (SRNA) Reports Revenue of $5.5 Million in Q3 2019, Second Straight Quarter of Record Revenue and Profits

Surna (OTCQB: SRNA) today released its operating and financial results for the three and nine months ended September 30, 2019. The company announced record-setting results in Q3 2019, including revenue of $5.5 million, an increase of 66% compared to the same quarter last year and growth of 31% compared to Q2 2019, Surna’s previous record high. “We are extremely pleased with our second straight quarter of record revenue and profits,” Surna CEO Tony McDonald said in the news release. “We continue to focus on our two key financial metrics: revenue growth and profitability. We also improved our cash position significantly—with a quarter-end cash balance of $2.0 million—and strong operating cash flows year-to-date. We believe the numbers speak for themselves.”

To view the full press release, visit http://cnw.fm/KE24r

About Surna Inc.

Surna Inc. is a Boulder, Colorado-based company that designs, engineers and manufactures environmental control and air sanitation systems for commercial, state- and provincial-regulated indoor cannabis cultivation facilities in the U.S. and Canada. Its engineering and technical team provides energy and water efficient solutions that allow growers to meet the unique demands of a cannabis cultivation environment through precise temperature, humidity, and process controls and to satisfy the evolving code and regulatory requirements being imposed at the state, provincial and local levels. Surna has been involved in consulting, equipment sales and/or full-scale design for over 800 grow facilities since 2006, making it a trusted resource for indoor environmental design and control management for the cannabis industry. For more information, visit the company’s website at www.Surna.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Reports Q2 Fiscal Year 2020 Financial Results, Provides Corporate Update

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning released its financial results for the three and six months ended September 30, 2019. The company’s unaudited condensed interim consolidated financial statements for Q2 2020, as well as its management’s discussion and analysis (“MD&A”) for Q2 2020, are available under its SEDAR profile and the company’s website. “Headlined by our graduation to the TSX, our business matured during the second quarter as we launched our Strategic Advisory Board and continued to work closely with our portfolio companies as they achieved new milestones,” Canopy Rivers president and CEO Narbé Alexandrian said in the news release. “There were numerous achievements for our portfolio companies this quarter. Several of these companies received licences and amendments from Health Canada for the sale of cannabis oils, while others made key acquisitions, launched their Canadian business, or brokered agreements with companies both inside and outside of the Canopy Rivers ecosystem. As we move forward, we plan to continue to develop a robust ecosystem of mutually beneficial cannabis companies intended to drive the industry forward and lay down the foundation for long-term success.”

To view the full press release, visit http://cnw.fm/7WHCs

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Enters Financing Arrangements for up to $103 Million

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, today announced its entry into signed arrangements for up to $103 million in funding. According to the update, the financing package consists of three elements: a definitive agreement for a sale-leaseback of the Ancaster Energy Centre; a construction mortgage loan term sheet; and a convertible equity note term sheet. “Our ability to raise capital, despite recent headwinds affecting the entire sector, is a clear show of confidence from our financial partners,” TGODF CEO Brian Athaide said in the news release. “It is reflective of the value of our significant assets, the trust investors are putting into TGODF’s strong corporate governance, transparency and accountability, and the opportunity for the company’s unique positioning to quickly capture and grow the organic segment.”

To view the full press release, visit http://cnw.fm/9rIIZ

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US-OTC: TGODF) is a premium, global, organic-cannabis company focused on the health and wellness market. Its certified-organic cannabis is grown in living soil, as nature intended. The company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities are built to LEED certification standards and its products are sold in recyclable packaging. In Canada, TGOD plans to expand its product portfolio by launching a series of next-generation cannabis products such as organic teas, infusers and vapes. Through its European subsidiary, HemPoland, the company also distributes premium hemp CBD oil in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale. For more information, visit the company’s website at www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://cnw.fm/TGOD

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – What You Need to Know to Grow Marijuana in a Greenhouse

Growers considering to enter into marijuana production are presented with several possibilities of where to grow. The options include indoors, outdoors, or greenhouses, which is a combination of indoor and outdoor.

There is an increase in popularity for greenhouse farming among marijuana growers. The efficient means of production has forced many cultivators to switch to greenhouse farming of marijuana. Greenhouses offer farmers the ability to control and protect their crops. It is also cost-saving. Besides, it provides the plants with the natural light of growing outdoors.

Marijuana produces high quality and quantity yields if efficient and sophisticated systems of cultivation are in place. Farmers need to consider several factors when planning a commercial marijuana operation in a greenhouse. These include the structure, roofing, and the equipment, which are discussed below.

The Structure Of The Greenhouse

The structure of your greenhouse is the most critical decision you will have to make when choosing a greenhouse for marijuana production. The gutter-connected greenhouse is a versatile option suitable for any grower, especially marijuana growers. Gutter-connected greenhouses are well ventilated, and it can be connected to other standalone greenhouses. They are economical for growers because they are designed to make maximum use of the available farming space. The ability to combine several individual greenhouses makes it easy to integrate service buildings such as mixing areas for fertilization, conditioning, and packaging, as well as the offices and employee lounges.

Another famous greenhouse structure amongst cannabis growers is the ground-to-ground greenhouse. It does not require as much initial investment as the gutter-connected greenhouse. They have a gothic shape that ensures the crops are exposed to a bright environment, thus promoting the uniform growth of plants. They also have a well-ventilated system with a stable climate.

You will have to establish the number of growing zones and square footage you want before choosing your structure. The method you are using to plant your marijuana, such as on the ground, double benches will determine how tall your plants will grow. Your greenhouse structure should be high enough to accommodate your crops.

Your Greenhouse Roofing

When it comes to choosing the roof for your greenhouse, you are presented with several options such as ETFE film, acrylic, polyethylene film, or glass. Apart from the unique characteristics of each option, they all provide excellent conditions for the optimal growth of the crop and access to light and UV rays. Higher UV levels help in increasing the THC levels in your plants.

Equipment for the Greenhouse

Choosing the right material for your greenhouse is as essential as selecting the structure and roofing. When selecting equipment, go for a company that has a reputation for creating the ideal conditions for quality yields. When setting up your greenhouse for operations, you will need to have equipment for heating, cooling, supplemental lighting, irrigation, light deprivation, ventilation, and pest control.

It is essential to consult a seasoned professional if you want great products and services for your greenhouse operation. Industry experts believe that established cannabis companies like Green Hygienics Holdings Inc. (OTCQB: GRYN) and IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) can point interested growers in the right direction so that they avoid making costly mistakes.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Clinical Trials of Cannabis as a Treatment for Pancreatic Cancer Expected

The United States Food and Drug Administration has granted a flavonoid of cannabis (Caflanone) the status of the Orphan Drug. It is estimated that within the next few months, the approved Orphan Drug will be used in clinical trials for treating pancreatic cancer. The clinical trials will involve human subjects.

Flavocure is a drug innovation and development company. The company developed the cannabis flavonoid Caflanone (FBL-03G). The U.S. Food and Drug Administration granted Caflanone the Orphan drug status after it was successful in reducing tumor progression in animals with pancreatic cancer through therapy.

The Executive Chairman of Flavocure, Dr. Henry Lowe, said that the company is happy for the designation of Orphan Drug status by the FDA for Caflanone. He further noted that the appointment is a momentous breakthrough for the Flavocure innovation and drug development program.

Dr. Lowe also said that they expect to start a clinical trial involving human subjects with the New Investigational Drug in the next few months. The clinical trials will be addressing pancreatic cancer.

He added that a new standard of care is required for effective and innovative treatment of pancreatic cancer, and as a recognized leader in the field of drug discovery and development, it is their responsibility to bring a new standard of care to the world.

Dr. Ngeh Toyang, the CEO of Flavocure, said that although less than 200,000 people have been diagnosed with pancreatic cancer per year, it is considered as the most common cause of death among cancer patients in the U.S.

Flavocure and the Harvard Medical School conducted pre-clinical studies and published their findings in the Frontiers in Oncology Journal. People from all over the world have been sending feedback and inquiries about the study results, and this has motivated Flavocure to commence the clinical trials for pancreatic cancer.

The drug granted the Orphan Drug status by the FDA, Caflanone, was derived from a prevalent Cannabis Sativa strain found in Jamaica.

Caflanone, which is rich in phytocannabinoids material, was discovered by Professor Lowe, University of Maryland Medical School, and University of the West Indies Medical School.

The Caflanone is now available commercially and can be used in human clinical studies. The Harvard Medical School developed a nano-drone delivery technology for Caflanone, which was approved by the FDA.

Harvard Medical School conducted pre-clinical studies using Caflanone and the drug portrayed great results in animal models with pancreatic cancer, which were difficult to treat. The medical and research community are optimistic about the potential of the drug. It has also aroused the interest of the patients.

President Ronald Reagan approved the Orphan Drug Act in 1983 to encourage companies to innovate and develop drugs that are geared towards helping patients suffering from rare diseases.

Companies which qualify for Orphan Drug designation receive benefit across all stages of drug development such as a speedy approval process, seven years of market exclusivity, and tax credits on U.S. clinical trials. They are also eligible for Orphan Drug grants, and a waiver of some administrative fees.

It is believed that the entire cannabis industry, including players like Marijuana Company of America Inc. (OTCQB: MCOA) and Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) could be waiting with crossed fingers for the outcome of this planned clinical trial that will expand the confirmed therapeutic benefits of marijuana for cancer patients.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Advances Development of Proprietary Drug-Delivery Platform

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, continues to progress the development and patenting of its DehydraTECH(TM) platform. An article discussing the company reads, “The DehydraTECH(TM) drug-delivery platform can be used to deliver substances in edible or in beverage form, and in capsules, pills, syrups and more. Brands in both Canada and the United States have licensed DehydraTECH to make their CBD and cannabis beverages best-in-class. . . . Not only is ingestion a much safer form of drug delivery, but DehydraTECH also delivers the active ingredient of the substance at a rate that is up to five to ten times faster compared with traditional edible products. A 2018 European clinical study demonstrated that 317% more CBD was delivered within half an hour when compared with a positive control of equal strength (http://cnw.fm/2T9z2). The substance being delivered is also rapidly absorbed, which means that people can achieve the effect they are looking for more quickly than was previously the case with edibles. For people looking for quick relief of pain, DehydraTECH is a blessing.”

To view the full article, visit http://cnw.fm/doX61

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a global innovator in drug-delivery platforms. Its patented DehydraTECH drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

HempNewsBreaks – SinglePoint Inc. (SING) Reports Record Q3 2019 Results, Expects Significant Growth in Solar and Hemp Businesses

Leading technology and acquisition company SinglePoint (OTCQB: SING) today announced its financial results for the third quarter ended September 30, 2019. According to the update, the company achieved revenues of $1,050,374 for the three months ended September 30, 2019, a 176% increase over the same period in 2018. Per the update, the initial response to the company’s Pure American Hemp Cigarette has been overwhelming, while Direct Solar, SinglePoint’s most recent acquisition, continues to exceed revenue targets and has been pivotal to the company’s financial growth. “This has been a great quarter for SinglePoint, we are very excited to see the growth of the company,” SING CEO Greg Lambrecht said in the news release. “We are establishing solid financials and we anticipate a big fourth quarter. Everything is firing on all cylinders and we continue to hit our numbers. We believe SinglePoint’s revenues will continue to grow as our subsidiary Direct Solar expands into new markets.”

To view the full press release, visit http://cnw.fm/fW1Qn

About SinglePoint Inc.

SinglePoint is a technology and acquisition company with a focus on acquiring companies that will benefit from management, capital and technology integration. The portfolio includes mobile payments, industrial hemp and renewable energy solutions. Through acquisitions into horizontal markets, the company is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through SingleSeed, SinglePoint provides products and services to the cannabis industry. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

CBDNewsBreaks – ChineseInvestors.com Inc.’s (CIIX) China Division Featured in WSJ Video on Opportunities to Cash In on US CBD Products Rush

ChineseInvestors.com’s (OTCQB: CIIX) China Division was featured in a video published by The Wall Street Journal today, which highlighted Chinese entrepreneurs and opportunities to cash in as products made with cannabidiol (“CBD”) take off in the U.S. The accompanying article, written by Stephanie Yang and Clément Bürge, highlighted the fact that, while marijuana is still seen as a dangerous narcotic in China, Chinese entrepreneurs “are navigating the highly-sensitive industry as they try to turn their country into a CBD superpower.” CIIX CEO Summer Sun, who leads the company’s Chinese branch, was featured in the video as he discussed the company’s products sold in the United States, including essential oils and gummy edibles that contain CBD, as well as his hopes to eventually sell these products in China.

To view the full article, visit http://cnw.fm/N3a3i

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.